BackOrtho Clinical Diagnostics Holdings plc Overview

Ortho Clinical Diagnostics Holdings plc Intangible Assets

Latest intangible assets for OCDX: $840M.

Get informed when a big investor buys or sells

+ Follow
Intangible Assets
$840.70M
14.51% YoYΔ $-142.70M vs prior year quarter

Peer trimmed avg / median

Loading

Ortho Clinical Diagnostics Holdings plc Intangible Assets History

Loading

Ortho Clinical Diagnostics Holdings plc vs. peers: Intangible Assets Comparison

Loading

Ortho Clinical Diagnostics Holdings plc Intangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Ortho Clinical Diagnostics Holdings plc (OCDX) FAQ

As of the most recent data (April 2022), OCDX shows a intangible assets of $840M. That compares with $980M in the prior-year period — down 14.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, OCDX's intangible assets is now $840M (was $980M) — a 14.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Ortho Clinical Diagnostics Holdings plc is outperforming or lagging.

Tracking OCDX's intangible assets over time shows whether Ortho Clinical Diagnostics Holdings plc is scaling, shrinking, or reshaping that part of the business. The current reading is $840M That compares with $980M in the prior-year period — down 14.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this intangible assets page, Stockcircle has Ortho Clinical Diagnostics Holdings plc's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect intangible assets (currently $840M) with ownership activity and broader fundamentals.

Ortho Clinical Diagnostics Holdings plc's intangible assets is $840M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.